ArticlePharmaceuticals (Basel, Switzerland)2021

Combined Treatment with Acalabrutinib and Rapamycin Inhibits Glioma Stem Cells and Promotes Vascular Normalization by Downregulating BTK/mTOR/VEGF Signaling.

Yu-Kai Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.